ZYUS Life Sciences Corporation
ZLSCF
$0.5323
$0.133833.58%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.36M | -24.68M | -24.39M | -26.86M | -27.12M |
| Total Depreciation and Amortization | 2.07M | 2.11M | 2.16M | 2.19M | 2.23M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.31M | 14.00M | 13.78M | 14.95M | 14.63M |
| Change in Net Operating Assets | -281.60K | 224.80K | -86.90K | 2.95M | -1.84M |
| Cash from Operations | -8.27M | -8.34M | -8.54M | -6.77M | -12.09M |
| Capital Expenditure | -8.80K | -8.80K | -34.00K | -174.40K | -192.40K |
| Sale of Property, Plant, and Equipment | 18.10K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.34M | 2.50M | 2.71M | 1.33M | 1.33M |
| Cash from Investing | 1.35M | 2.49M | 2.68M | 1.15M | 1.13M |
| Total Debt Issued | 8.96M | 7.45M | 5.70M | 700.00K | 400.00K |
| Total Debt Repaid | -2.86M | -2.86M | -3.04M | -3.36M | -1.31M |
| Issuance of Common Stock | 3.31M | 3.31M | 3.31M | 3.31M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.73M | 5.64M | 4.28M | 476.00K | -679.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -186.20K | -205.30K | -1.58M | -5.14M | -11.64M |